Precision Biologics, Inc.
Regenerative medicine products derived from biological materials
- Sector
- Biotech
- Headquarters
- Rockville, MD
- Founded
- 2012
- Latest Form D
- $53.1M, Oct 2015
- Total capital
- $71.9M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $71.9M
- 5 Form D · last Oct 2015
- 132 months since last filing
- Federal contracts
- $26K
- 1 award · Veterans Affairs
- Rank in Biotech#366 of 4373
- Granted patents
- 25
- 15 pending · first 2015
- Rank in peer group#69 of 1449
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 5th filing$53.1M
- Private capital raisedForm D · SEC · 4th filing$795K
- Private capital raisedForm D · SEC · 3rd filing$10.5M
- Federal contractVeterans Affairs · Express Report - Prosthetics - VA262-14-P-0727$26K
- Private capital raisedForm D · SEC · 2nd filing$2.2M
- Private capital raisedForm D · SEC · 1st filing$5.3M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1449 peers
Line = medianBiotech · Molecule
- Granted patents#69 · top 5%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Philip M. ArlenResearcherExecutive Officer, DirectorLinked by 1 patent
- Albine K MartinExecutive OfficerNamed in SEC Form D filings
- C. Brent HaggardDirectorNamed in SEC Form D filings
- Charles M. KimDirectorNamed in SEC Form D filings
- Christian M. ZapfDirectorNamed in SEC Form D filings
- Mark B KristenDirectorNamed in SEC Form D filings
Show all 12 people
- Patrick M. Soon-ShiongDirectorNamed in SEC Form D filings
- R.J. B ChildressExecutive OfficerNamed in SEC Form D filings
- Robert A WashingtonExecutive OfficerNamed in SEC Form D filings
- Severin B RussoDirectorNamed in SEC Form D filings
- Sheldon B RabinDirectorNamed in SEC Form D filings
- Stanley B Archibald, Jr.Director, PromoterNamed in SEC Form D filings
What it has protected
USPTO · 25 granted of 40- PendingHumanized Monoclonal Antibodies And Methods Of Use For The Diagnosis And Treatment Of Colon And Pancreas CancerUSPTOApplication 19574885
- PendingRecombinant Monoclonal Antibodies And Corresponding Antigens For Colon And Pancreatic CancersUSPTOApplication 19375867
- PendingColon and Pancreas Cancer PeptidomimeticsUSPTOApplication 19367897
Show all 40 patent records
- Humanized Monoclonal Antibodies And Methods Of Use For The Diagnosis And Treatment Of Colon And Pancreas CancerSep 17, 2026 · Application 19574885Pending
- Recombinant Monoclonal Antibodies And Corresponding Antigens For Colon And Pancreatic CancersApr 30, 2026 · Application 19375867Pending
- Colon and Pancreas Cancer PeptidomimeticsApr 23, 2026 · Application 19367897Pending
- Humanized Monoclonal Antibodies And Methods Of Use For The Diagnosis And Treatment Of Colon And Pancreas CancerApr 21, 2026 · US 12,606,621Granted
- Methods For Ablating Myeloid Derived Suppressor Cells Using NEO-201 AntibodyMar 26, 2026 · Application 18867032Pending
- Recombinant Monoclonal Antibodies And Corresponding Antigens For Colon And Pancreatic CancersJan 15, 2026 · Application 19218689Pending
- Recombinant Monoclonal Antibodies And Corresponding Antigens For Colon And Pancreatic CancersNov 4, 2025 · US 12,460,013Granted
- Colon and Pancreas Cancer PeptidomimeticsOct 28, 2025 · US 12,454,560Granted
- Anti-cancer Antibodies, Combination Therapies, And Uses ThereofOct 23, 2025 · Application 19039402Pending
- Recombinant Monoclonal Antibodies And Corresponding Antigens For Colon And Pancreatic CancersJul 1, 2025 · US 12,344,676Granted
- Methods And Compositions For Targeting Treg CellsDec 5, 2024 · Application 18737186Pending
- Methods And Compositions For Treating Hematological MalignanciesNov 21, 2024 · Application 18290553Pending
- Methods And Compositions For Targeting Treg CellsJul 16, 2024 · US 12,037,410Granted
- Recombinant Monoclonal Antibodies And Corresponding Antigens For Colon And Pancreatic CancersApr 9, 2024 · US 11,952,429Granted
- Monoclonal Antibody NEO-201 For The Treatment Of Human CarcinomasMar 28, 2024 · Application 18472411Pending
- Monoclonal Antibody NEO-201 For The Treatment Of Human CarcinomasSep 26, 2023 · US 11,767,367Granted
- Recombinant Monoclonal Antibodies And Corresponding Antigens For Colon And Pancreatic CancersFeb 7, 2023 · US 11,572,413Granted
- Colon And Pancreas Cancer Specific Antigens And AntibodiesFeb 2, 2023 · Application 17739400Pending
- Humanized Monoclonal Antibodies And Methods Of Use For The Diagnosis And Treatment Of Colon And Pancreas CancerNov 22, 2022 · US 11,505,604Granted
- Recombinant Monoclonal Antibodies And Corresponding Antigens For Colon And Pancreatic CancersAug 2, 2022 · US 11,401,341Granted
- Colon And Pancreas Cancer Specific Antigens And AntibodiesMay 31, 2022 · US 11,345,733Granted
- Anti-cancer Antibodies, Combination Therapies, And Uses ThereofMar 22, 2022 · US 11,279,768Granted
- Colon and Pancreas Cancer PeptidomimeticsAug 3, 2021 · US 11,078,245Granted
- Monoclonal Antibody Therapy For Pancreas CancerMay 11, 2021 · US 11,001,641Granted
- Humanized Monoclonal Antibodies And Methods Of Use For The Diagnosis And Treatment Of Colon And Pancreas CancerJun 23, 2020 · US 10,689,443Granted
- Colon And Pancreas Cancer PeptidomimeticsJan 14, 2020 · US 10,533,040Granted
- Recombinant Monoclonal Antibodies And Corresponding Antigens For Colon And Pancreatic CancersJul 30, 2019 · US 10,364,295Granted
- Recombinant Monoclonal Antibodies And Corresponding Antigens For Colon And Pancreatic CancersDec 6, 2018 · Application 16009497Pending
- Recombinant Monoclonal Antibodies And Corresponding Antigens For Colon And Pancreatic CancersJul 17, 2018 · US 10,023,650Granted
- Humanized Monoclonal Antibodies and Methods of Use for the Diagnosis and Treatment of Colon and Pancreas CancerApr 10, 2018 · US 9,938,344Granted
- Colon And Pancreas Cancer PeptidomimeticsAug 1, 2017 · US 9,718,866Granted
- Monoclonal Antibody Therapy For Pancreas CancerJul 27, 2017 · Application 15417326Pending
- Recombinant Monoclonal Antibodies And Corresponding Antigens For Colon And Pancreatic CancersMar 28, 2017 · US 9,605,077Granted
- Monoclonal Antibody Therapy For Pancreas CancerMar 14, 2017 · US 9,592,290Granted
- Recombinant Monoclonal Antibodies And Corresponding Antigens For Colon And Pancreatic CancersJun 21, 2016 · US 9,371,375Granted
- Colon And Pancreas Cancer PeptidomimeticsJun 30, 2015 · US 9,068,014Granted
- Monoclonal Antibody Therapy For Pancreas CancerMay 19, 2015 · US 9,034,588Granted
- Monoclonal Antibody NEO-201 For The Treatment Of Human CarcinomasApplication PCTUS2018059039Pending
- High Affinity Antibodies Recognizing Core 2 O-glycans Of Variant MUC5AC Antigen, Compositions Containing And Uses ThereofApplication PCTUS2024047509Pending
- High Affinity Antibodies Recognizing Core 2 O-glycans Of Variant MUC5AC Antigen, Compositions Containing And Uses ThereofApplication 63688904Pending
Related companies, and why
- G-SPACE INCSimilar federal contract value in Biotech · $35K in contracts
- Epicypher, Inc.Similar federal contract value in Biotech · $33K in contracts
- Day One BiopharmaceuticalsSimilar federal contract value in Biotech · $26K in contracts
- SPECTRAGEN INFORMATICS, LLCSimilar federal contract value in Biotech · $25K in contracts
- ARC Medical Inc.Similar federal contract value in Biotech · $24K in contracts
- LIFESENSORS, INC.Similar federal contract value in Biotech · $24K in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .